Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Acta Neuropathol. 2018 May;135(5):671-679. doi: 10.1007/s00401-018-1822-2. Epub 2018 Feb 15.

Abstract

Amyloid-β (Aβ) is a peptide deposited in the brain parenchyma in Alzheimer's disease and in cerebral blood vessels, causing cerebral amyloid angiopathy (CAA). Aβ pathology is transmissible experimentally in animals and through medical procedures in humans, such as contaminated growth hormone or dura mater transplantation in the context of iatrogenic prion disease. Here, we present four patients who underwent neurosurgical procedures during childhood or teenage years and presented with intracerebral haemorrhage approximately three decades later, caused by severe CAA. None of these patients carried pathogenic mutations associated with early Aβ pathology development. In addition, we identified in the literature four patients with a history of neurosurgical intervention and subsequent development of CAA. These findings raise the possibility that Aβ pathology may be transmissible, as prion disease is, through neurosurgical procedures.

Keywords: Amyloid-β; Aβ; CAA; Cerebral amyloid angiopathy; Decontamination; Head trauma; Intracerebral haemorrhage; Neurosurgery; Prion diseases; Proteopathic seeding; TBI; Transmission; Traumatic brain injury.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain / pathology
  • Brain / surgery
  • Cerebral Amyloid Angiopathy / etiology*
  • Cerebral Amyloid Angiopathy / genetics
  • Cerebral Amyloid Angiopathy / pathology
  • Fatal Outcome
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neurosurgical Procedures*
  • Postoperative Complications* / genetics
  • Postoperative Complications* / pathology
  • Retrospective Studies